Globeflex Capital L P acquired a new stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 38,270 shares of the company's stock, valued at approximately $307,000. Globeflex Capital L P owned about 0.10% of Viemed Healthcare at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Wasatch Advisors LP lifted its stake in shares of Viemed Healthcare by 19.6% in the third quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company's stock worth $13,552,000 after buying an additional 303,277 shares during the last quarter. Rice Hall James & Associates LLC acquired a new position in Viemed Healthcare during the 4th quarter worth $2,083,000. First Eagle Investment Management LLC lifted its position in Viemed Healthcare by 196.5% during the 4th quarter. First Eagle Investment Management LLC now owns 328,824 shares of the company's stock worth $2,637,000 after acquiring an additional 217,923 shares during the last quarter. Victory Capital Management Inc. boosted its holdings in Viemed Healthcare by 748.2% during the third quarter. Victory Capital Management Inc. now owns 108,497 shares of the company's stock valued at $795,000 after acquiring an additional 95,706 shares during the period. Finally, JPMorgan Chase & Co. grew its position in shares of Viemed Healthcare by 151.7% in the third quarter. JPMorgan Chase & Co. now owns 98,798 shares of the company's stock valued at $724,000 after purchasing an additional 59,538 shares during the last quarter. 74.24% of the stock is currently owned by institutional investors.
Viemed Healthcare Stock Performance
Shares of NASDAQ VMD traded down $0.22 during trading hours on Thursday, hitting $7.36. 70,740 shares of the company's stock were exchanged, compared to its average volume of 133,751. The company's 50-day moving average price is $7.94 and its 200-day moving average price is $8.20. Viemed Healthcare, Inc. has a 1-year low of $6.21 and a 1-year high of $9.81. The stock has a market capitalization of $290.88 million, a price-to-earnings ratio of 27.26 and a beta of 1.50. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19.
Viemed Healthcare Profile
(
Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Featured Stories

Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.